✦ LIBER ✦

5-Bromo-2'-deoxycytidine (BCDR)-I. Studies on metabolism in vitro and in mice

✍ Scribed by William H. Prusoff; John W. Cramer; Ming Y. Chu; Arnold D. Welch

Book ID: 115767521
Publisher: Elsevier Science
Year: 1961
Tongue: English
Weight: 255 KB
Volume: 8
Category: Article
ISSN: 0006-2952
DOI: 10.1016/0006-2952(61)90108-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5-Bromo-2'-deoxycytidine (BCDR)-II. Stud

5-Bromo-2'-deoxycytidine (BCDR)-II. Studies with murine neoplastic cells in culture and in vitro

✍ John W. Cramer; William H. Prusoff; Arnold D. Welch 📂 Article 📅 1961 🏛 Elsevier Science 🌐 English ⚖ 429 KB

Transformation and metabolic effects of

Transformation and metabolic effects of 5-aza-2'-deoxycytidine in mice

✍ Alois Čihak; Jiřǐ Vesely̌; Sixtus Hynie 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 542 KB

Studies on the biochemical pharmacology

Studies on the biochemical pharmacology of 5-IODO-2'-deoxycytidine in vitro and in vivo

✍ John W. Cramer; William H. Prusoff; Arnold D. Welch; Alan C. Sartorelli; Irvine 📂 Article 📅 1962 🏛 Elsevier Science 🌐 English ⚖ 643 KB

Effects of 5-azacytidine and 5-aza-2-deo

Effects of 5-azacytidine and 5-aza-2-deoxycytidine on alphafetoprotein levels in mice

✍ Y.T. Behnam; N. Maclean 📂 Article 📅 1990 🏛 Elsevier Science ⚖ 537 KB

Phase I study on 5-aza-2′-deoxycytidine

Phase I study on 5-aza-2′-deoxycytidine in children with acute leukemia

✍ Georges E. Rivard; Richard L. Momparler; Jocelyn Demers; Paul Benoit; Richard Ra 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 709 KB

Phase I study on 5-aza-2′-deoxycytidine

Phase I study on 5-aza-2′-deoxycytidine in children with acute leukemia

✍ Georges E. Rivard; Richard L. Momparler; Jocelyn Demers; Paul Benoit; Richard Ra 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 709 KB

Ahstract--A Phase I study with 5-aza-2'-deoxycytidine (5-AZA-CdR) was performed on children with acute leukemia who were resistant to conventional chemotherapy. The objective of this study was to find the dose-schedule of 5-AZA-CdR that produced a potent antileukemic effect and to evaluate its toxic